4.8 Article

Endoscopic or Surgical Myotomy in Patients with Idiopathic Achalasia

Journal

NEW ENGLAND JOURNAL OF MEDICINE
Volume 381, Issue 23, Pages 2219-2229

Publisher

MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMoa1905380

Keywords

-

Funding

  1. European Clinical Research Infrastructure Network (ECRIN)
  2. Hamburgische Stiftung fur Wissenschaften, Entwicklung und Kultur Helmut und Hannelore Greve (Hamburg, Germany)
  3. Dr. med. Carl-August Skroder Stiftung (Hamburg, Germany)
  4. Dr. Gerhard Buchtemann Stiftung (Hamburg, Germany)
  5. Agnes-Graefe Stiftung (Hamburg, Germany)
  6. Georg und Jurgen Rickertsen Stiftung (Hamburg, Germany)
  7. Reinhard Frank Stiftung (Hamburg, Germany)
  8. Johann Max Bottcher Stiftung (Hamburg, Germany)
  9. Richard und Annemarie Wolf Stiftung (Knittlingen, Germany)
  10. Olympus Europa (Hamburg, Germany) [206/7, 2017/18]
  11. German Society for Gastroenterology and Metabolism
  12. Olympus Europe Foundation (Endoscopy Research Award 2012)
  13. Olympus Euro-NOTES Research Fund Program
  14. Harvard Catalyst, the Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health Award) [UL 1TR002541]
  15. Harvard University

Ask authors/readers for more resources

BACKGROUND Pneumatic dilation and laparoscopic Heller's myotomy (LHM) are established treatments for idiopathic achalasia. Peroral endoscopic myotomy (POEM) is a less invasive therapy with promising early study results. METHODS In a multicenter, randomized trial, we compared POEM with LHM plus Dor's fundoplication in patients with symptomatic achalasia. The primary end point was clinical success, defined as an Eckardt symptom score of 3 or less (range, 0 to 12, with higher scores indicating more severe symptoms of achalasia) without the use of additional treatments, at the 2-year follow-up; a noninferiority margin of -12.5 percentage points was used in the primary analysis. Secondary end points included adverse events, esophageal function, Gastrointestinal Quality of Life Index score (range, 0 to 144, with higher scores indicating better function), and gastroesophageal reflux. RESULTS A total of 221 patients were randomly assigned to undergo either POEM (112 patients) or LHM plus Dor's fundoplication (109 patients). Clinical success at the 2-year follow-up was observed in 83.0% of patients in the POEM group and 81.7% of patients in the LHM group (difference, 1.4 percentage points; 95% confidence interval [CI], -8.7 to 11.4; P = 0.007 for noninferiority). Serious adverse events occurred in 2.7% of patients in the POEM group and 7.3% of patients in the LHM group. Improvement in esophageal function from baseline to 24 months, as assessed by measurement of the integrated relaxation pressure of the lower esophageal sphincter, did not differ significantly between the treatment groups (difference, -0.75 mm Hg; 95% CI, -2.26 to 0.76), nor did improvement in the score on the Gastrointestinal Quality of Life Index (difference, 0.14 points; 95% CI, -4.01 to 4.28). At 3 months, 57% of patients in the POEM group and 20% of patients in the LHM group had reflux esophagitis, as assessed by endoscopy; at 24 months, the corresponding percentages were 44% and 29%. CONCLUSIONS In this randomized trial, POEM was noninferior to LHM plus Dor's fundoplication in controlling symptoms of achalasia at 2 years. Gastroesophageal reflux was more common among patients who underwent POEM than among those who underwent LHM.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available